VšĮ Infekcinių ligų ir patogeninės mikrobiologijos institutas Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 104,438 |
| 34,731 |
| 0 |
| - |
| - |
| - |
| - |
| 50,555 |
| 5,346 |
| 20,014 |
| 35,887 |
| 2024 |
|---|
| 238,417 |
| 77,061 |
| 0 |
| - |
| - |
| - |
| - |
| 146,460 |
| 19,583 |
| 19,536 |
| 146,507 |
| 2025 |
|---|
| 27,148 |
| 7,800 |
| 0 |
| - |
| - |
| - |
| - |
| 74,412 |
| 11,534 |
| 32,079 |
| 53,867 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 27,148 |
| 7,800 |
| 0 |
| - |
| - |
| - |
| - |
| 74,412 |
| 11,534 |
| 32,079 |
| 53,867 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
27,148 €-89 % *
Sales per employee (€)
7,800 €-90 % *
Profit before tax (€)
0 €- *
Net Profit (€)
-Profit per employee (€)
-Total profitability (%)
-Net profitability (%)
-Equity (€)
74,412 €-49 % *
Amounts Payable And Liabilities (€)
11,534 €-41 % *
Non-current Assets (€)
32,079 €64 % *
CurrentAssets (€)
53,867 €-63 % *
